Fragmentation of Halohexopyranosides
471
General procedure for the fragmentation of benzyl
protected iodoglycosides "conditions A and B)
To a solution of 500 mg ꢀ0.87 mmol) methyl 2,3,4-tri-O-benzyl-6-deoxy-6-iodo-ꢀ-D-glycopyrano-
side in 20 cm3 THF, 569 mg ꢀ8.7 mmol) pre-activated zinc and 0.11 cm3 ꢀ0.87 mmol) TMSC1
ꢀcondition A) or 2.2 cm3 H2O ꢀcondition B) were added. The resulting suspension was sonicated
at 40ꢀC until TLC showed full conversion ꢀA: 4±6 h, B: 1 h). Then, 30 cm3 diethyl ether and
10 cm3 H2O were added. The resulting biphasicsystem was ®ltered, and the layers were
3
separated. The organicphase was washed with 10 cm H2O, 10 cm3 brine, dried ꢀK2CO3), ®ltered,
and concentrated to give a bright yellow syrup which was puri®ed by ¯ash chromatography
ꢀhexane:ethyl acetate 5:1).
2,3,4-Tri-O-benzyl-5,6-dideoxy-D-xylo-hex-5-enose ꢀ3; C27H28O4)
Colorless syrup; spectroscopic data in accordance with literature [7].
2,3,4-Tri-O-benzyl-5,6-dideoxy-D-lyxo-hex-5-enose ꢀ11; C27H28O4)
Colorless syrup; spectroscopic data in accordance with literature [7].
2,3,4-Tri-O-benzyl-5,6-dideoxy-L-arabino-hex-5-enose ꢀ12; C27H28O4)
1
Colorless syrup; Rf 0.45 ꢀhexane:ethyl acetate 5:1); H NMR ꢀCDCl3, 500 MHz): ꢁ 9.62 ꢀd,
J 1.7 Hz, 1 H), 7.40±7.20 ꢀm, 15H), 5.90 ꢀddd, J 17.5, 10.2, 7.7 Hz, 1 H), 5.44 ꢀdd, J 17.5,
1.7 Hz, 1 H), 5.42 ꢀdd, J 10.2, 1.7 Hz, 1 H), 4.65 ꢀd, J 12.0 Hz, 1 H), 4.61 ꢀd, J 11.1 Hz, 1 H),
4.56 ꢀd, J 11.5 Hz, 1 H), 4.55 ꢀd, J 11.5 Hz, 1 H), 4.50 ꢀd, J 11.1 Hz, 1 H), 4.20 ꢀd, J 11.5 Hz,
1 H), 4.11±4.08 ꢀm, 2H), 3.89 ꢀdd, J 7.7, 3.8 Hz, 1 H) ppm; 13C NMR ꢀCDCl3, 125 MHz):
ꢁ 202.43, 137.84, 137.50, 137.18, 135.47, 128.35, 128.23, 128.16, 128.07, 127.96, 127.73, 127.70,
127.52, 120.16, 83.92, 81.20, 79.23, 74.24, 73.39, 70.06 ppm.
General procedure for fragmentation of unprotected iodoglycosides "condition C)
To a solution of 200 mg ꢀ0.66 mmol) methyl 6-deoxy-6-iodo-ꢀ-D-glycopyranoside in 12 cm3 THF
and 3 cm3 H2O, 430 mg ꢀ6.6 mmol) pre-activated zinc were added, and the resulting suspension
was sonicated at 40ꢀC for 1 h. The reaction mixture was then ®ltered and concentrated to
approximately 5 cm3. The resulting solution was puri®ed by reverse phase ¯ash chromatography
eluting with H2O.
5,6-Dideoxy-D-xylo-hex-5-enofuranose ꢀ13; C6H10O4)
Colorless syrup; Rf 0.21 ꢀCHCl3:MeOH 9:1); spectroscopic data in accordance with literature
[12].
5,6-Dideoxy-D-lyxo-hex-5-enofuranose ꢀ14; C6H10O4)
Colorless syrup; Rf 0.24 ꢀCHCl3:MeOH 9:1); 4:1 mixture of ꢀ:ꢂ anomers; 1H NMR ꢀD2O,
500 MHz): ꢀ-anomer: ꢁ 5.86 ꢀddd, J 17.5, 10.5, 7.0 Hz, 1 H), 5.37±5.29 ꢀm, 2H), 5.25 ꢀd,
J 4.5 Hz, 1 H), 4.19±4.13 ꢀm, 2H), 4.09 ꢀt, J 4.5 Hz, 1 H) ppm; ꢂ-anomer: ꢁ 5.23 ꢀd, J 5.0 Hz,
1 H) ppm; 13C NMR ꢀD2O, 125 MHz): ꢀ-anomer: ꢁ 133.32, 120.18, 101.34, 82.03, 78.25,
73.50 ppm, ꢂ-anomer: ꢁ 134.18, 119.90, 96.12, 82.21, 72.45, 72.13 ppm.